Coulie Bernard's Form 4 filing
Pliant Therapeutics, Inc. (PLRX) · filed Jul 13, 2022
- Accession no.
- 0001567619-22-013993
- Filed
- Jul 13, 2022
- Trade date
- Jul 11-12, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $618.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coulie BernardCIK 0001808895 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 11, 2022 | Common Stock | MOption exerciseAcquired | +15,000 | $2.08 | +$31,200 | 74,273 | Direct | |
| Jul 11, 2022 | Common Stock | SSaleDisposed | −15,000 | $22.50 | −$337,500 | 59,273 | Direct | |
| Jul 12, 2022 | Common Stock | MOption exerciseAcquired | +12,498 | $2.08 | +$25,995.84 | 71,771 | Direct | |
| Jul 12, 2022 | Common Stock | SSaleDisposed | −12,498 | $22.50 | −$281,205 | 59,273 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 11, 2022 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 322,380 | Direct | |
| Jul 12, 2022 | Common Stock | MOption exerciseDisposed | −12,498 | $0.00 | $0 | 309,882 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.